Daniel Bessesen, chief endocrinologist at the University of Colorado School of Medicine, May 6, 2026 Biomolecules, Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss, March 13, 2025 BMJ, Weight regain after cessation of medication for weight management: systematic review and meta-analysis, Jan
The following represents commonly discussed research frameworks, not medical recommendations
This prevents the confusion of "is it injection day back home or here?" that leads to accidental double-dosing or skipping
This meticulous process is designed to ensure that you receive safe, effective, and truly personalized care, guiding you toward achieving your health and weight loss goals responsibly
GLP-1 agonists are incredibly effective at reducing appetite and increasing feelings of fullness (satiety)
What doesnt change is the nature of the loss